Voluntary announcement: legend announces preliminary sales for CARVYKTI for the quarter ended 30 September 2026
Filed with HKEX · Stock code 1548 · · 2 pages · English
Summary by 6ix AI
Genscript Biotech Corporation has made a voluntary announcement regarding preliminary sales for CARVYKTI for a specific quarter. The sales figure is based on information provided by Janssen Biotech, Inc., and has not been independently verified by either Legend or Genscript. The filing includes cautionary notes about forward-looking statements and potential investment risks.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Genscript Biotech Corporation on 6ix
Earlier from Genscript Biotech
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Change in board lot size
- Announcement pursuant to rule 13.10 of the listing rules
- List of directors and their role and function
- Passing away of an independent non-executive director and change in composition of board committees
Follow Genscript Biotech into a list and get an email when it puts out news.
Follow Genscript Biotech